Please use this identifier to cite or link to this item:
Title: The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial Pneumonia
Author: François, Bruno
Chastre, Jean
Eggiman, Philippe
Laterre, Pierre-François
Torres Martí, Antoni
Sanchez, Miguel
Esser, Mark T.
Bishop, Brian
Bonten, Marc
Goosens, Herman
Jafri, Hasan S.
Keywords: Pneumònia
Assaigs clínics de medicaments
Drug testing
Issue Date: 15-Aug-2016
Publisher: Oxford University Press
Abstract: The Innovative Medicines Initiative-funded COMBACTE consortium fosters academic-industry partnership in pioneering studies to combat serious bacterial infections. We describe how this partnership is advancing the development of 2 monoclonal antibodies, MEDI4893 and MEDI3902, for the prevention of nosocomial pneumonia.
Note: Versió postprint del document publicat a:
It is part of: Clinical Infectious Diseases, 2016, vol. 63, num. Suppl 2, p. S46-S51
Related resource:
ISSN: 1058-4838
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
665243.pdf144.34 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.